Immunome
Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consis...
Immunome Logo
About Immunome
Immunome, Inc. is a biopharmaceutical company. The Company focuses on the development of targeted oncology therapies. Immunome serves patients in the State of Washington.
Address
18702 N. Creek Parkway, Suite 100
Bothell, 98011
United States
Year founded
2015
Number of employees
100-200
Report inaccurate data
Request an update to help us keep the brand up-to-date.
